Tag: COVID-19

The CSIR is working with Intel India and International Institute of Information Technology (IIIT), Hyderabad, to help achieve faster and less expensive COVID-19 testing and coronavirus genome sequencing to understand the epidemiology and Artificial Intelligence (AI)-based risk stratification for patients with co-morbidities................

Revenues of the healthcare sector likely to witness a 15-20% decline due to Covid-19, EBIDTA and debt protection ratio too may fall sharply

Pune based pioneer in the field of drug repurposing in India, NovaLead Pharma has received ‘in principle’ clinical trial permission with DCG(I) for its Repurposed Drug discovery to treat moderate COVID-19............................

In an exclusive interaction with the BioVoice, Dr Rishi Bhatnagar, President, Aeris Communications, and Chairperson of The Institution of Engineering and Technology - IoT panel talked about various aspects of dealing with pandemic including the role of technology and communication.....................

BiPAP Ventilator is an electronic breathing device used in the treatment of sleep apnea, lung disease, and to treat respiratory weakness.....................

Jubilant Life Sciences Limited got the rights to register, manufacture and sell Gilead’s investigational drug, remdesivir, a potential therapy for Covid-19 in 127 countries including India.....................

Dr Girish N. S., Head of Nephrology, Department, Columbia Asia Hospitals (Hebbal) offers his advice on managing kidney health during these COVID-19 times, and the lockdown period...................

It has been suggested that the severity of COVID-19 is higher in countries that do not have a history of Bacillus Calmette–Guerin (BCG) vaccination programs. Clinical trials are underway to investigate the possibility that they confer some immunity to COVID-19.......................

NIRAMAI Health Analytix, a deep-tech startup with expertise in thermal imaging and AI, is offering an Automated FeverTest for COVID screening that helps identify likely infected people at the entrances of hospitals, workplaces, and public places..............

Indian response so far has been commendable despite the expanse of challenges in a country that is as large and socio-economically complex, writes Pushpa Vijayaraghavan......................